INTRODUCTION
The first recorded outbreak of severe acute respiratory syndrome (SARS) since late February 2003 has led to thousands of infected patients and hundreds of deaths. The aetiological agent of the syndrome, a novel coronavirus termed SARS-associated coronavirus (SARS-CoV), has since been identified and isolated, [1] [2] [3] [4] and its genome sequenced. 5, 6 SARS is characterized by high fever, rigor, headache, nonproductive cough or dyspnea and may progress to generalized, interstitial infiltrates in the lung, requiring intubation and mechanical ventilation. 1, 2, [7] [8] [9] A common observation in patients with SARS is pronounced lymphopenia. 1, 10, 11 A notable drop in CD4 + and CD8 + T lymphocyte counts occurrs early in the course of the disease and is associated with adverse outcomes. 12 To date, studies on SARS have generally been retrospective or limited to the description of initial clinical, haematological, radiological and microbiological findings. Further studies to evaluate the mechanisms of these manifestations may help us to better understand this disease.
Evidence suggests that CD8 + cytotoxic T lymphocytes (CTLs) play a pivotal role in both virus elimination and induction of immunopathology in respiratory syncytial virus (RSV) infection, following recognition of epitopes presented on target cells in the context of MHC class I. [13] [14] [15] [16] [17] Similarly, CTLs may participate in the clearance of virus in recovered SARS patients, but also contribute to immunopathology in early stages of the disease; the molecular mechanisms underlying these CD8 + CTL-mediated effects remain poorly defined. HLA-A*0201 is the most common HLA-A allele in Asian populations, particularly in the Chinese, with an estimated frequency of greater than 50%. 18 As SARS affected many parts of Asia, and a reservoir of infection may persist in these regions, the identification of HLA-A*0201-restricted CTL epitopes was used. 22 The OVA-derived H-2 b -restricted peptide OVA 257-264 (SIINFKEL) was used as a negative control. Lyophilized peptides were dissolved in PBS at a concentration of 2mg/ml and stored in aliquots at -80°C.
Animals and cell lines
HLA-A2.1/K b transgenic (Tg) mice 23 were purchased from The Jackson Laboratory (Bar Harbor, ME). Mice were bred and maintained in specific pathogen free facilities. For experimental purposes, mice were used at 6-8 weeks of age. Cell surface HLA-A*0201 expression was assessed by flow cytometry using fluorescein isothiocyanate (FITC)-labeled HLA-A2. 
Peptide binding assay
To determine whether synthetic peptides could bind to HLA-A*0201 molecules, peptide-induced HLA-A*0201 up-regulation on T2 cells was examined according to a protocol described previously. 24, 25 Briefly, T2 cells were incubated with 50µM candidate peptides and 3 µg/ml human 2 -microglobulin (Sigma, St. Louis, MO) in serum-free Iscove's modified Dulbecco's medium for 18 hours at 37°C in a 5% CO 2 atmosphere. Expression of HLA-A*0201 on T2 cells was then 
Recombinant adenovirus preparation and infection
The ORF of SARS/S cDNA was amplified by PCR using forward (5'-GCCTCGAGACCATGTTTATTTTCTTATTATTTCTTACTCTCACTAGTGGTAGTGACCT -3') and reverse (5'-TTTATGTGTAATGTAATTTGACACCCTT -3') primers from a plasmid containing the SARS/S cDNA sequence obtained from SARS-CoV BJ01 strain 19 . The PCR product was digested by Xho I and inserted into pShuttle-CMV vector (Stratagene, La Jolla, CA).
After confirmation by DNA sequencing, the linearized shuttle vector was co-transformed into E.coli strain BJ5183 together with pAdEasy-1, the supercoiled viral DNA plasmid (Stratagene, La Jolla, CA). The recombinant adenovirus plasmid DNA containing SARS/S or -galactosidase ORF was designated as pAd-SARS/S or pAd-LacZ respectively. Recombinant adenoviruses were propagated in 293 cells and the titers of which were determined by plaque assay on 293 cells as 25, [27] [28] [29] [30] [31] [32] [33] [34] In this study, bone marrow-derived DCs were generated from transgenic mice as previously described by us. 35 On day 7, DCs were harvested and washed. For induction of peptide-specific CTLs, DCs were pulsed with 20 µg/ml peptides in the presence of 3µg/ml 2-microglobulin. After incubation at 37°C for 3 hours, cells were washed three times in PBS and resuspended in PBS for injections. HLA-A2.1/K b transgenic mice were immunized intraperitoneally with 1×10 6 DCs/mouse weekly, for three weeks. Seven days after the last immunization, splenic single-cell suspensions from primed mouse spleens were cultured in six-well plates at a density of 1×10 7 cells / well, in the presence of 1×10 6 10µg/ml peptide-loaded irradiated syngeneic DCs. On day 6 of culture, induced cells were harvested and tested by enzyme-linked immunospot (ELISPOT), cytotoxicity and tetramer staining assays.
Generation of CTLs in healthy donors
Dendritic cells are characterized by the unique capacity to activate naïve T cells and initiate primary T-cell response. [36] [37] [38] Antigen-specific T-cell responses from peripheral blood mononuclear cells (PBMCs) can be elicited with antigenic peptide-or protein-pulsed autologous DCs.
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Here, PBMCs were isolated from whole blood of eleven healthy HLA-A2.1 + volunteer donors by Ficoll/Hypaque (Sigma, St. Louis, MO) density gradient centrifugation. Human peripheral blood monocyte-derived DCs were generated as previously described by us. 44 On day 5 of culture, 10 ng/mL recombinant human tumor necrosis factor alpha (TNF-) (Peprotech Inc. Rocky Hill, NJ) was added to the medium to induce phenotypic and functional maturation. 48 hours later, DCs were pulsed with 20 µg/ml peptide in the presence of 3 µg/ml 2 -microglobulin at 37°C for 3
hours and irradiated at 30 Gy before use. Lymphocytes were restimulated each week in the same manner. Seven days after the fourth round of restimulation, cells were harvested and tested by ELISPOT assay, cytotoxicity assay and tetramer staining. For ELISPOT assay and cytotoxicity assays, CD8 + T lymphocytes were purified by CD4 + cell negative depletion using human CD4 microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany)
Cytotoxicity assay
Cultured CTLs were tested for cytotoxicity in a standard 4-hour 51 Cr release assay. 45, 46 T2 cells were loaded with 20 µg/ml peptide at 37°C for 1 hour. Peptide-pulsed T2 cells and SARS/S-expressing tumor cell lines were labeled with 51 Cr sodium chromate (100µCi/10 6 cells)
for 90 minutes at 37°C. 51 Cr-labeled target cells were washed three times and mixed with graded doses of effectors in 96-well round-bottom tissue culture plates. After incubation at 37°C for 4 hours, a total of 100 µl supernatant was collected from each well and radioactivity was counted with a gamma counter. Each assay was performed in triplicate. Percent specific lysis was determined according to the following formula: percent specific lysis = [(mean experimental cpmmean spontaneous cpm)/(mean maximum cpm -mean spontaneous cpm)] x 100%. Spontaneous and maximum release were determined by incubating the labeled targets with medium alone or 2%
Triton X-100, respectively. Spontaneous release was always <15% of maximum release. The standard deviation (SD) of triplicate wells was less than 15%.
ELISPOT assay
ELISPOT assays were performed using a commercially available kit (R&D Systems, Minneapolis, 
Tetramer production and staining
Tetrameric HLA-A*0201-peptide complexes (tetramers) containing SSp-1 were constructed as previously described by us. 26 Briefly, DNA encoding the 14-amino acid residues recognized by the Peptide-induced lymphocyte cultures were first incubated with PE-conjugated tetramers for 1 hour at 37°C, then FITC-labeled anti-human/mouse CD8 mAb (PharMingen, San Diego, CA) was added and cells incubated for an additional 30 minutes at 4°C. After washing with PBS, stained cells were fixed with 0.5% paraformaldehyde and analysed by flow cytometry. 24, 27, [47] [48] [49] For personal use only. on October 23, 2017. by guest www.bloodjournal.org From
Results

Selection of potential HLA-A2.1-binding peptides from SARS-CoV spike protein
Based on computer software predictions, the twenty candidate nonameric peptides with the highest estimated half-time of dissociation from HLA-A*0201 were selected and synthesized (Table 1) . To evaluate the binding affinity of these peptides to HLA-A*0201 molecules, we used a T2 cell-peptide binding test. This assay measures the increase of HLA-A*0201 molecules induced on T2 cells following exposure to exogenous HLA-A*0201-binding peptides, with high-affinity peptides inducing HLA-A*0201 up-regulation more strongly than low-affinity peptides.
Of the 20 candidate peptides, only No.5 and No.13 were high-affinity epitopes (FI=1.1 and 1.7, respectively); all other peptides were of low affinity (FI 1, Table 1 ). The positive control CAP-1 bound HLA-A*0201 strongly (FI=1.9) whereas no binding was associated with the negative control (FI=0.1). 
In vitro generation of peptide-specific CD8 + CTLs from healthy human donor PBLs
To investigate the capacity of SSp-1 to mobilize a human CTL repertoire, SSp-1-specific CTLs were generated by in vitro sensitization of healthy HLA-A2.1 + donor PBLs with autologous DCs pre-pulsed with SSp-1. In over 60% (7/11) of healthy HLA-A2.1 + individuals tested, SSp-1-specific CD8 + T cells were generated. To determine the antigen specificity of in vitro-induced CTLs, T2 cells and autologous DCs were pulsed with SSp-1 and used as stimulators
and/or targets in ELISPOT and cytotoxicity assays. Human CTLs produced IFN-in response to
SSp-1 in a concentration-dependent manner, but not to the irrelevant peptide CAP-1 (Figure 2A,B) .
In vitro generated effectors lysed T2 cells pulsed with SSp-1 but did not lyse target cells alone or CAP-1-pulsed T2 cells ( Figure 2C ). 
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Frequencies of SSp-1-specific CD8 + T cells determined by tetramer staining
To visualize and enumerate SSp-1-specific CD8 + T cells from amongst lymphocytes induced either in vitro from healthy donor PBLs or in vivo in Tg mice, we constructed phycoerythrin (PE)-labeled HLA-A*0201-peptide tetramers containing the nonameric peptide SSp-1. These tetramers were designed to specifically bind to SSp-1-reactive T-cell clones but not unreactive clones. Virtually no specific tetramer-staining could be detected in splenocyte preparations from 
tetramers with T cell receptors (TCR). Another
For personal use only. on . by guest www.bloodjournal.org From candidate peptide, No.5, failed to induce significant peptide-specific CTLs in Tg mice, despite its high binding affinity for HLA-A*0201, indicating the need for peptides predicted by computer algorithms to be biofunctionally validated. Peptide-MHC tetramers should be able to bind more than one TCR on a specific T cell, and thus have correspondingly slower dissociation rates. CD8 binding significantly enhances the avidity as well as the stability of interactions between TCR and cognate tetramers. 50, 51 It is notable that human HLA-A2/peptide tetramers can only detect high affinity TCR on murine CTLs 27,52,53 since murine CD8 does not bind human HLA-A2 molecules and therefore that cytotoxicity assays would be more sensitive than HLA-A2-restricted tetramer binding for murine CTLs in the HLA-A2 transgenic mice.
Spike protein is a major structural glycoprotein of coronaviruses. The mature spike protein is inserted into the viral envelope, with most of the protein exposed on the surface of viral particles.
Spike protein molecules associate in group of three to form the characteristic corona-like structures of this virus family. 6 In some coronaviruses, the spike protein has been identified as the protein responsible for both entry of the virus into susceptible cells and also for eliciting neutralizing antibody from the host. [54] [55] [56] [57] In this study, an endogenously processed and presented peptide derived from the SARS-CoV spike protein could induce significant CTL responses in
PBLs from healthy human donors, suggesting that CTL precursor populations against SARS/S exist within the T-cell repertoire of normal individuals. CTL reactivity is postulated to be important in control of virus replication and in pathogenesis of SARS, but the exact mechanisms remain unclear.
In addition to CTL-mediated immunopathology, host genes that affect the viral receptor, virus production, and immune responses to infection can determine the outcome of coronavirus (5) Apoptosis may also contribute to SARS-associated lymphopenia. 63 Respiratory syncytial virus (RSV) disease, measles, and sepsis show parallels to SARS, in that they also cause lymphopenia.
In SARS, apoptotic cells including pneumocytes, lymphocytes and monocytes, and CD68 + monocytes are observed in abundance in the lung, spleen and lymph nodes at postmortem examination. 64 In models of sepsis, inhibitors of apoptosis ameliorate illness and prevent death, 65 pointing to important therapeutic implications for patients with SARS. Interestingly, the mean B lymphocyte count remains stable in peripheral blood of SARS patients, 8, 12 with 100 percent of patients exhibiting antibody responses to SARS-CoV, with typical IgM and IgG profiles, during the convalescent phase. 58, 66 In pulmonary reovirus infection in athymic mice, a lower plaque-forming value of 10 6 is associated with pathological changes consistent with bronchiolitis obliterans organising pneumonia, whereas a higher inoculum of 10 7 is associated with development of the more serious acute respiratory distress syndrome (ARDS). 67 To lessen the risk of progression to ARDS, an effective antiviral strategy to reduce the viral load may be important; decreasing the initial cytolytic damage and viral load at the onset may in turn result in decreased immunopathological damage. 8 Thus, we must seek to maintain a fine balance between CTL-induced immune protection and pathology in the treatment of SARS disease. The HLA-A*0201-SSp-1 tetramers we and by extrapolation, SARS-specific CD8 + T cell numbers as a whole, in the peripheral blood of SARS patients during clinical or therapeutic treatments, providing an additional indicator for treatment efficacy and short/long-term prognosis.
In conclusion, our study has identified a novel HLA-A*0201-restricted, immunogenic CD8 
